Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emine-Selin Demir"'
Autor:
Evren Gundogdu, Emine-Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem-Ozdemir, Zeynep Senyigit, Isabel Gonzalez-Alvarez, Marival Bermejo
Publikováno v:
Nanomaterials, Vol 12, Iss 2, p 250 (2022)
Imatinib (IMT) is a tyrosine kinase enzyme inhibitor and extensively used for the treatment of gastrointestinal stromal tumors (GISTs). A nanostructured lipid carrier system (NLCS) containing IMT was developed by using emulsification–sonication met
Externí odkaz:
https://doaj.org/article/eb81636e80164718be67c99506151091
Autor:
Meliha Ekinci, Derya Ilem-Ozdemir, Emre Ozgenc, Bárbara Sánchez-Dengra, Evren Atlihan-Gundogdu, Isabel González-Álvarez, Emine Selin Demir
Publikováno v:
Journal of Pharmaceutical Investigation. 50:349-361
The cancer is serious health problem and leading cause of death in the world. There have intensively studied for diagnosis and therapy of this disease and these studies provided important insights into their mechanism of action and therapeutic/diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2da8d54a467b3519c687335d718c1517
https://doi.org/10.1007/s40005-020-00473-0
https://doi.org/10.1007/s40005-020-00473-0
Publikováno v:
ACS Omega
ACS Omega, Vol 5, Iss 10, Pp 5297-5305 (2020)
ACS Omega, Vol 5, Iss 10, Pp 5297-5305 (2020)
The clinical impact and accessibility of Tc-99m tracers for cancer diagnosis would be greatly enhanced by the availability of a new, simple, and easy labeling process and radiopharmaceuticals. in this study, Technetium-99m-imatinib mesylate ([Tc-99m]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1639a731ed87e324129961d7fa48cbc2
https://hdl.handle.net/20.500.12939/223
https://hdl.handle.net/20.500.12939/223
Publikováno v:
ACS Omega, Vol 5, Iss 10, Pp 5297-5305 (2020)
Externí odkaz:
https://doaj.org/article/d4fade7dbcbd46b8a5c411b2b13479d1
Autor:
Evren Atlihan Gundogdu, Emine Selin Demir, Meliha Ekinci, Emre Ozgenc, Derya Ilem Ozdemir, Zeynep Senyigit, Makbule Asikoglu
Publikováno v:
Drug Delivery, Vol 27, Iss 1, Pp 1695-1703 (2020)
The aim of current study is to develop new nanostructured lipid carrier systems (NLCSs) containing imatinib mesylate (IMT) and evaluate their targeting efficiency on NIH-3T3 as fibroblast cells and CRL-1739 as gastric adenocarcinoma cells with radiol
Externí odkaz:
https://doaj.org/article/6e4c8f012dc5489b8d1cb87b2cfd4055